ALPS Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,036
Closed -$342K 1012
2023
Q1
$342K Sell
33,036
-802
-2% -$8.31K ﹤0.01% 706
2022
Q4
$400K Buy
33,838
+6,627
+24% +$78.3K ﹤0.01% 677
2022
Q3
$571K Sell
27,211
-2,594
-9% -$54.4K 0.01% 571
2022
Q2
$925K Sell
29,805
-22,100
-43% -$686K 0.01% 494
2022
Q1
$2.13M Sell
51,905
-10,355
-17% -$425K 0.02% 196
2021
Q4
$2.71M Sell
62,260
-3,559
-5% -$155K 0.03% 213
2021
Q3
$3.3M Sell
65,819
-8,100
-11% -$406K 0.03% 205
2021
Q2
$4.66M Sell
73,919
-25,607
-26% -$1.61M 0.04% 179
2021
Q1
$9.25M Buy
99,526
+1,287
+1% +$120K 0.09% 146
2020
Q4
$8.8M Buy
98,239
+28,120
+40% +$2.52M 0.1% 145
2020
Q3
$7.25M Sell
70,119
-1,399
-2% -$145K 0.11% 143
2020
Q2
$5.66M Buy
+71,518
New +$5.66M 0.08% 148
2019
Q4
Sell
-102,901
Closed -$5.38M 827
2019
Q3
$5.38M Sell
102,901
-4,260
-4% -$223K 0.04% 137
2019
Q2
$5.18M Sell
107,161
-16,506
-13% -$797K 0.04% 153
2019
Q1
$6.25M Sell
123,667
-1,096
-0.9% -$55.4K 0.04% 145
2018
Q4
$7.4M Buy
124,763
+28,929
+30% +$1.71M 0.06% 129
2018
Q3
$6.31M Buy
95,834
+15,294
+19% +$1.01M 0.04% 145
2018
Q2
$4.07M Buy
80,540
+5,180
+7% +$262K 0.03% 184
2018
Q1
$3.97M Buy
75,360
+17,266
+30% +$909K 0.03% 163
2017
Q4
$2.7M Buy
58,094
+5,283
+10% +$246K 0.02% 174
2017
Q3
$2.14M Buy
52,811
+15,844
+43% +$641K 0.02% 182
2017
Q2
$1.25M Buy
36,967
+1,964
+6% +$66.6K 0.01% 210
2017
Q1
$1.02M Sell
35,003
-3,915
-10% -$114K 0.01% 216
2016
Q4
$1.28M Sell
38,918
-12,660
-25% -$416K 0.01% 200
2016
Q3
$1.63M Sell
51,578
-16,730
-24% -$527K 0.01% 197
2016
Q2
$1.92M Buy
68,308
+11,000
+19% +$309K 0.02% 171
2016
Q1
$2.08M Buy
57,308
+6,008
+12% +$218K 0.02% 149
2015
Q4
$2.05M Sell
51,300
-9,432
-16% -$377K 0.02% 175
2015
Q3
$17.3K Buy
60,732
+22,701
+60% +$6.47K 0.02% 180
2015
Q2
$1.25M Buy
38,031
+19,216
+102% +$633K 0.01% 198
2015
Q1
$541K Buy
+18,815
New +$541K ﹤0.01% 331
2014
Q3
Sell
-21,856
Closed -$491K 626
2014
Q2
$491K Buy
21,856
+556
+3% +$12.5K ﹤0.01% 530
2014
Q1
$538K Buy
+21,300
New +$538K 0.01% 528